Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Showing results for: ���� ������
https://wis-wander.weizmann.ac.il/chemistry/weizmann-institute-led-project-receives-center-excellence-grant
October 20, 1996
REHOVOT, Israel -- October 20, 1996 -- A Center of Excellence research grant has been awarded to a project being coordinated by a Weizmann Institute of Science professor. The project, a study of the molecular processes involved in vision, was the only one selected from 11 proposa...
https://wis-wander.weizmann.ac.il/earth-sciences/system-also-used-explain-saltiness-sea-galilee
October 31, 1996
REHOVOT, Israel -- October 31, 1996 -- A Weizmann Institute of Science groundwater sampling system, recently recognized by the US Environmental Protection Agency as useful sampling technology, tracks down microscopic particles that act as vehicles for the spread of groundwater po...
https://wis-wander.weizmann.ac.il/earth-sciences/environmentally-friendly-building-dedicated-weizmann-institute
November 13, 1996
REHOVOT, Israel -- November 13, 1996 -- An environmentally friendly building designed to rely as little as possible on energy from polluting fossil fuels was dedicated this week at Israel's Weizmann Institute. The Sussman Family Building for Environmental Scie...
https://wis-wander.weizmann.ac.il/life-sciences/breaking-super-relationship
June 14, 1996
REHOVOT, Israel -- June 14, 1996 -- A key enzyme that acts as a "suicide weapon" causing cells to self-destruct has been discovered by Weizmann Institute researchers. This finding, reported in the June 14 issue of Cell, may help in the design of treatmen...
https://wis-wander.weizmann.ac.il/life-sciences/potential-weight-loss-drug-may-be-linked-adult-diabetes
November 15, 1996
REHOVOT, Israel -- November 15, 1996 -- Leptin, the protein that made headlines two years ago when it was found to reduce obesity in mice, may be a cause of adult-onset diabetes in humans, according to a new Weizmann Institute of Science study. The study, to be published in...
https://wis-wander.weizmann.ac.il/life-sciences/new-drug-multiple-sclerosis-approved-us-food-and-drug-administration
December 23, 1996
REHOVOT, Israel -- December 23, 1996 -- The U.S. Food and Drug Administration today announced the approval of the Israeli drug copolymer-1, to be marketed under the brand name COPAXONE, for treatment of patients with relapsing-remitting multiple sclerosis. Copolymer-1 (...
https://wis-wander.weizmann.ac.il/study-shows-how-ancient-chinese-herb-may-act-alzheimer-drug
January 1, 1997
REHOVOT, Israel -- January 1, 1997 -- A new Weizmann Institute study shows exactly how a substance derived from a moss long used in Chinese folk medicine blocks a brain enzyme that may be involved in Alzheimer disease. In the study, reported in the January issue of N...
https://wis-wander.weizmann.ac.il/chemistry/surface-things
January 2, 1997
From pens to pans, from hard disks to compact discs, an increasing number of products are made of polymers, giant complex molecules with repeating structural units. Different polymers are often mixed together in liquid form and then allowed to harden in order to i...
https://wis-wander.weizmann.ac.il/earth-sciences/new-solar-technology-be-implemented-under-us-israeli-agreement
March 10, 1997
REHOVOT, Israel - March 10, 1997 - McDonnell Douglas and Israel's Ormat Industries Ltd., Rotem Industries Ltd. and the Weizmann Institute of Science, through its commercial arm, Yeda Research and Development Co. Ltd., have been awarded $5.3 million by the U.S.-Israel Science and...
https://wis-wander.weizmann.ac.il/people/weizmann-institute-professor-leo-sachs-wins-harvard-medical-schools-warren-alpert-foundation
March 18, 1997
REHOVOT, Israel -- March 18, 1997 -- Prof. Leo Sachs of the Weizmann Institute of Science has been awarded Harvard Medical School's Warren Alpert Foundation Prize. Given "in recognition of scientific discoveries leading to improved understanding and treatment of disease...
Pages
Press Releases
Weizmann in the Media
The Sun
18.11.2020
Times of Israel
18.11.2020